Squamous cell carcinoma of the lower lip: FAS/FASL expression, lymphocyte subtypes and outcome

被引:33
作者
Somma, P
Lo Muzio, L
Mansueto, G
Delfino, M
Fabbrocini, G
Mascolo, M
Mignogna, C
Di Benedetto, M
Carinci, F
De Lillo, A
Pastore, L
Serpico, R
De Rosa, G
Staibano, S
机构
[1] Univ Naples Federico II, Sect Pathol, Dept Biomorphol & Funct Sci, Naples, Italy
[2] Univ Foggia, Dept Surg Sci, Foggia, Italy
[3] Univ Naples Federico II, Dept Clin & Expt Med, Naples, Italy
[4] Univ Naples Federico II, Dept Syst Pathol, Dermatol Sect, Naples, Italy
[5] Univ Ferrara, Dept DMDDD, I-44100 Ferrara, Italy
[6] Univ Bari, Dept Dent & Surg, Bari, Italy
关键词
squamous cell carcinoma; lymphocytes; FAS; FAS-L; lip;
D O I
10.1177/039463200501800107
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
Squamous cell carcinoma (SCC) of the lip is a relatively common malignancy of the head and neck region. Tumour thickness, grading and perineural invasion are significant prognostic indicators. However, there is still the need of new reliable biological markers able to predict the prognosis of the single cases with an unfavourable biological behaviour unpredictable by the classic clinical-pathological parameters. 32 cases of (SCC) of the lower lip were analysed for their clinicopathologic features, and immunohistochemical expression of Fas/FasL in neoplastic cells and in inflammatory infiltrate. Moreover the density and phenotype of tumour-infiltrating lymphocytes (TIL) were analysed. The results were related with the follow-up of the patients ranging from 2 to 6 years. The cases with over-expression of Fas/FasL in neoplastic cells and Fas+ in T cells preferentially showed a more aggressive clinical behaviour (P<0.01). Moreover we found an alteration of the normal expression of CD4 and CD8 lymphocyte types in ten cases. This data suggest that the Fas/FasL pathway is involved in the close relation between neoplastic cells and T cells and so in the biological behaviour of these tumours.
引用
收藏
页码:59 / 64
页数:6
相关论文
共 37 条
[1]
LYSIS OF AUTOLOGOUS MELANOMA-CELLS BY TUMOR-INFILTRATING LYMPHOCYTES - ASSOCIATION WITH CLINICAL-RESPONSE [J].
AEBERSOLD, P ;
HYATT, C ;
JOHNSON, S ;
HINES, K ;
KORCAK, L ;
SANDERS, M ;
LOTZE, M ;
TOPALIAN, S ;
YANG, J ;
ROSENBERG, SA .
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1991, 83 (13) :932-937
[2]
Lymphatic mapping and sentinel lymph node biopsy in squamous cell carcinoma of the lower lip [J].
Altinyollar, H ;
Berberoglu, U ;
Çelen, O .
EUROPEAN JOURNAL OF SURGICAL ONCOLOGY, 2002, 28 (01) :72-74
[3]
Altinyollar H, 2002, J EXP CLIN CANC RES, V21, P29
[4]
Inflammation and cancer: back to Virchow? [J].
Balkwill, F ;
Mantovani, A .
LANCET, 2001, 357 (9255) :539-545
[5]
Bennett MW, 1998, J IMMUNOL, V160, P5669
[6]
Management of lower lip cancer: A retrospective analysis of 118 patients and review of the literature [J].
Bilkay, U ;
Kerem, H ;
Ozek, C ;
Gundogan, H ;
Guner, U ;
Gurler, T ;
Akin, Y .
ANNALS OF PLASTIC SURGERY, 2003, 50 (01) :43-50
[7]
T cell-tumor cell: a fatal interaction? [J].
Chappell, DB ;
Restifo, NP .
CANCER IMMUNOLOGY IMMUNOTHERAPY, 1998, 47 (02) :65-71
[8]
DANIEL PT, 1994, J IMMUNOL, V152, P5624
[9]
de Visscher J G A M, 2002, Ned Tijdschr Tandheelkd, V109, P391
[10]
FIEDLER P, 1998, SCIENCE, V279, P2015